tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Alterity Therapeutics Announces Quotation of New Securities on ASX

Story Highlights
Alterity Therapeutics Announces Quotation of New Securities on ASX

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Alterity Therapeutics ( (AU:ATH) ) has shared an announcement.

Alterity Therapeutics Limited announced the quotation of 1,666,666,663 fully paid ordinary securities on the Australian Securities Exchange (ASX) as of September 15, 2025. This move is part of a previously announced transaction, potentially enhancing the company’s financial flexibility and market presence, which could have implications for its strategic initiatives and stakeholder interests.

More about Alterity Therapeutics

Alterity Therapeutics Limited operates in the biotechnology industry, focusing on developing therapies for neurodegenerative diseases. The company primarily works on treatments that target conditions like Alzheimer’s and Parkinson’s disease, aiming to address significant unmet medical needs in these areas.

YTD Price Performance: 20.0%

Average Trading Volume: 13,499,487

Technical Sentiment Signal: Sell

Current Market Cap: A$115.1M

Find detailed analytics on ATH stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1